uu.seUppsala universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)
Catharina Hosp, Dept Surg, POB 1350, NL-5602 ZA Eindhoven, Netherlands;Univ Padua, Surg Clin 1, Dept Surg Oncol & Gastroenterol, Padua, Italy.
Catharina Hosp, Dept Surg, POB 1350, NL-5602 ZA Eindhoven, Netherlands.
Veneto Inst Oncol IOV IRCCS, Unit Surg Oncol Esophagus & Digest Tract, Castelfranco Veneto, TV, Italy.
MedStar Washington Hosp Ctr, Ctr Gastrointestinal Malignancies, 106 Irving St NW,Suite 3900, Washington, DC 20010 USA.
Visa övriga samt affilieringar
2018 (Engelska)Ingår i: European Journal of Surgical Oncology, ISSN 0748-7983, E-ISSN 1532-2157, Vol. 44, nr 12, s. 1942-1948Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: At present, selected patients with resectable colorectal peritoneal metastases (CRC-PM) are increasingly treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this study was to investigate the current worldwide practice.

Methods: HIPEC experts from 19 countries were invited through the Peritoneal Surface Oncology Group International (PSOGI) to complete an online survey concerning their personal expertise and current hospital and country wide practice.

Results: It is estimated that currently more than 3800 patients with CRC-PM (synchronous and metachronous) are annually treated with CRS and HIPEC in 430 centers. Integration of CRS and HIPEC in national guidelines varies, resulting in large treatment disparities between countries. Amongst the experts, there was general agreement on issues related to indication, surgical technique and follow up but less on systemic chemotherapy or proactive strategies.

Conclusion: This international survey demonstrates that CRS and HIPEC is now performed on a large scale for CRC-PM patients. Variation in treatment may result in heterogeneity in surgical and oncological outcomes, emphasising the necessity to reach consensus on several issues of this comprehensive procedure. Future initiatives directed at achieving an international consensus statement are needed.

Ort, förlag, år, upplaga, sidor
ELSEVIER SCI LTD , 2018. Vol. 44, nr 12, s. 1942-1948
Nyckelord [en]
Colorectal peritoneal metastases, Cytoreductive surgery, Hyperthermic intraperitoneal chemotherapy
Nationell ämneskategori
Kirurgi
Identifikatorer
URN: urn:nbn:se:uu:diva-373016DOI: 10.1016/j.ejso.2018.07.003ISI: 000452943200016PubMedID: 30075978OAI: oai:DiVA.org:uu-373016DiVA, id: diva2:1277504
Tillgänglig från: 2019-01-10 Skapad: 2019-01-10 Senast uppdaterad: 2019-01-10Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Cashin, Peter

Sök vidare i DiVA

Av författaren/redaktören
Cashin, Peter
Av organisationen
Gastrointestinalkirurgi
I samma tidskrift
European Journal of Surgical Oncology
Kirurgi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 119 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf